Drawing for ZELLBRIDGE VANDEFITEMCEL

USPTO serial 79295147

ZELLBRIDGE VANDEFITEMCEL

Reviewed by CopyMark Law Group

Reg. 6714877Status 700Registered
Filing date
Status date
Registration date
May 3, 2022
Examiner
CIANCI, RYAN MICHAEL
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ZELLBRIDGE VANDEFITEMCEL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Stem cells for medical and veterinary purposes; pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of traumatic brain injury, cerebral infarction, cerebral hemorrhage, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury, and Alzheimer's disease; all the aforementioned being vandefitemcel that are stem cells affecting fibroblasts for use during cell therapyACTIVE
010Apparatus for the regeneration of stem cells for medical purposes; medical apparatus and instruments used for cell culture, namely, for cell culture chambers; medical apparatus and instruments, namely, cell testing apparatus in the nature of medical diagnostic apparatus for testing cancer cells, DNA, blood cells and extra cellular contents; medical apparatus and instruments, namely, intracellular material injector for medical purposes in the nature of injection instrument with needles, needle-based and needle-free injection systems; medical apparatus and instruments for monitoring vital signs, for use in orthopedic surgery; medical apparatus and instruments for analyzing substances for medical purposes, namely, blood and cell analyzers for medical diagnostics; medical apparatus and instruments, namely, test tubes for cell separation for medical purposes in the nature of blood testing apparatus, namely, blood sampling tubes; medical apparatus and instruments, namely, apparatus for the regeneration of stem cells for medical purposes; gene and genetic testing apparatus in the nature of apparatus for DNA and RNA testing for medical purposes; medical apparatus and instruments, namely, cell injector for medical purposes in the nature of injection instrument with needles; medical apparatus and instruments, namely, needle-based and needle-free injection systems; implants consisting of artificial materials; artificial implants in the nature of surgical implants comprised of artificial materials and artificial vascular graftsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 26, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Sep 2, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB
Sep 2, 2022FIMPFINAL DISPOSITION PROCESSED
Sep 2, 2022LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Aug 15, 2022LIMGLIMITATION OF GOODS RECEIVED FROM IB
Aug 3, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 3, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 26, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 9, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 9, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 20, 2022GPNXNOTIFICATION PROCESSED BY IB
Feb 15, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 15, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 26, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 26, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 26, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 7, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jan 5, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jan 5, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 5, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 15, 2021RFNPREFUSAL PROCESSED BY IB
Jul 12, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 12, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 12, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 16, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jun 16, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 16, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 4, 2021RFNTREFUSAL PROCESSED BY IB
Dec 16, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 16, 2020RFRRREFUSAL PROCESSED BY MPU
Dec 3, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 2, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 24, 2020DOCKASSIGNED TO EXAMINER
Oct 17, 2020MAFRAPPLICATION FILING RECEIPT MAILED
Oct 13, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 8, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance